Carbamazepine toxicity: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Treatment==" to "==Management==") |
Neil.m.young (talk | contribs) (Text replacement - " w/ " to " with ") |
||
| Line 17: | Line 17: | ||
==Diagnosis== | ==Diagnosis== | ||
*Levels do not accurately correlate | *Levels do not accurately correlate with clinical severity | ||
==Management== | ==Management== | ||
Revision as of 22:42, 11 July 2016
Background
- Has anticholinergic and antiepileptic effects
- Therapeutic concentration: 4-12
Clinical Features
- May be delayed and follow crescendo-decrescendo course (due to delayed GI motility)
- CNS
- Ataxia
- Nystagmus
- Coma
- Anticholinergic Toxicity
- CV
- Dysrhythmias are rare but may occur
- Wide QRS
- QT Prolongation
Diagnosis
- Levels do not accurately correlate with clinical severity
Management
- GI detox
- Activated Charcoal (if presents w/in 1hr of ingestion)
- Dialysis is effective (if needed)
Disposition
- Consider discharge for patient with decreasing levels (measured few hrs apart) and is asymptomatic